New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
08:40 EDTMDXGMiMedx EpiFix allograft awarded coverage by HCSC
MiMedx Group announced that Health Care Services Corporation, HCSC, has confirmed that the company's EpiFix allograft has been awarded reimbursement coverage. HCSC has approved the reimbursement of EpiFix for the indications as prescribed by the physician, including wound care, soft tissue replacement or repairs in burns, cardiovascular applications, treatment of ocular surfaces, and the application as a surgical barrier in knee or spine surgeries. The company also reported that its EpiFix allograft currently has reimbursement approval from 12 state Medicaid Programs.
News For MDXG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 27, 2015
07:25 EDTMDXGMiMedx developing into regenerative medicine play, says Canaccord
Canaccord believes MiMedx is developing a platform technology based regenerative medicine company leveraging its amniotic tissue technology. The firm sees the ground work being laid via distribution and clinical data that will drive growth in 2016 and beyond. Canaccord reiterated its Buy rating and $14 price target on MiMedx shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use